Biotech Financial Reports articles

Recent articles from Biotech Financial Reports

BIO-REFERENCE 2ND QTR HAS INCREASE OF 16% FOR FISCAL 2009.(Financial report)
July 1, 2009... Laboratories, Inc. (NASDAQ: BRLI), Elmwood Park,N.J., has released its second quarter, fiscal year 2009 earnings for the three months ending April 30. The company recorded current quarter revenues of $87,183, the best ever quarter in corporate history and an increase of 16% over the $75,180...

ALPHA-1 TO GET $1 MILLION IN MATCHING FUNDS FROM TALECRIS.(Talecris Biotherapeutics Inc.)
July 1, 2009... The Alpha-1 Foundation will receive up to $1 million in grant matching funds from Talecris Biotherapeutics, Inc. to support research into alpha1-antitrypsin deficiency, a genetic condition in which low levels of the essential blood protein alpha1-proteinase inhibitor, can cause emphysema. ...

ZILA REPORTS FISCAL 2009 3RD QTR NET REVENUES OF $8.5 MIL.(Financial report)
July 1, 2009... Zila, Inc. (Nasdaq:ZILA), Scottsdale, Ariz., has reported financial results for its fiscal 2009 third quarter ended April 30, 2009. "During the third quarter, revenues remained steady, and our cash position increased compared with the previous quarter," said David Bethune, chairman and chief...

BIOTECH BUSINESS CONTINUITY AND RECOVERY STRATEGIES.
May 1, 2009... Business continuity planning (BCP) is put into action by companies to prevent disruptions in operations. In the area of pharmaceutical and biotech manufacturing, it is extremely critical that raw materials are received in a timely manner to prevent disruptions in manufacturing, and...

CARDIUM HIGHLIGHTS/FINANCIAL RESULTS AND 2009 OUTLOOK.
May 1, 2009... Cardium Therapeutics (NYSE Amex: CXM), San Diego, has reported highlights and financial results for its fourth quarter and fiscal year ended December 31, 2008, and other important recent developments and outlook for 2009. Recent Developments and 2009 Outlook Cardium's business is...